Publications Using MCE Products

Patent:US 2014/0303235 Al Animal Feed Science and Technology.DOI: 10.1016/j.anifeedsci. (2014). Biomed Chromatogr. (2014). J Steroid Biochem Mol Biol. pii: S0960-0760(14)00203-9. (2014). J Cell Physiol. doi: 10.1002/jcp.24835. (2014). Science. 346(6205):1255784. (2014). J Med Chem. (2014). Biochem Biophys Res Commun. pii: S0006-291X(14)01696-9. (2014). J Virol. 88(20):11872-85. (2014). J Physiol. (2014). Antiviral Res. pii: S0166-3542(14)00255-1. (2014). Clin Cancer Res. pii: clincanres.0902. (2014). Br J Pharmacol. doi: 10.1111/bph.12889. (2014). Acta Neuropathol Commun. 2(1):98. (2014). Blood Cancer J. 4:e240.(2014). Neurobiol Dis. DOI: 10.1016/j.nbd.2014.08.005. (2014). J Virol. pii: JVI.01867-14. (2014). Chem Biol.18(6):679-80.(2011) Leukemia. doi: 10.1038/leu. (2014) Nat Med. doi: 10.1038/nm.3610 (2014). Nature. doi: 10.1038/nature13485 (2014). Arch Virol. (2014). Spectrochim Acta A Mol Biomol Spectrosc.131:347-54 (2014). Cell Death Dis. 5:e1338.(2014). PLoS One. 9(7):e100985. (2014). Environ Toxicol Pharmacol. (2014). Stem Cell Research (2014). Antimicrob Agents Chemother. pii: AAC.03534-14 (2014). BioMed Research International. (2014). Chem Biol Drug Des. (2014). Sci Rep. 4:5411 (2014). PLoS One. 9(6):e99083 (2014). Chem Res Toxicol.27(6):949-51 (2014). Biochem Biophys Res Commun. pii: S0006-291X(14)00930-9 (2014). DNA Repair (Amst).pii: S1568-7864(14)00121-9 (2014). ACS Nano.8(6):5468-77 (2014). Biomaterials. pii: S0142-9612(14)00440-2 (2014). Eur Urol. pii: S0302-2838(14)00396-0 (2014). Spectrochim Acta A Mol Biomol Spectrosc.131:347-54 (2014). Virology.456-457:300-9 (2014). Trends Pharmacol Sci. pii: S0165-6147(14)00017-0 (2014). Mol Pain.10(1):10 (2014). Ann Hematol.(2014). Biopolymers.101(4):391-7 (2014). BMC Musculoskelet Disord. 15(1):18 (2014). PLoS One. 9(1):e85780 (2014). Cancer Res. 74(1):15-23 (2014). Am J Physiol Lung Cell Mol Physiol.306(2):L207-15 ( 2014). ACS Nano. 24;8(6):5468-77(2014). Pharmacology 85, 365-371 (2010). Cancer research 73, 5206-5217 (2013). Clinical Cancer Research 19, 598-609 (2013). Cancer research 73, 2574-2586 (2013). J Pharm Biomed Anal. 66:232-9.66, 232-239 (2012). Journal of Alzheimer's Disease 21, 1005-1012 (2010). Journal of bioenergetics and biomembranes 44, 155-161 (2012). International immunopharmacology 15, 38-41 (2013). Current Biology 23, 1514-1526 (2013). European journal of pharmacology 663, 74-79 (2011). Cancer research 73, 2574-2586 (2013). Science translational medicine 5, 196ra199-196ra199 (2013). PloS one 8, e56473 (2013). Hypertension 60, 1207-1212 (2012). American Journal of Physiology-Heart and Circulatory Physiology 299, H1309-H1317 (2010). European journal of nuclear medicine and molecular imaging 40, 1739-1747 (2013). J Pharm Pharmacol. 66(4):574-83 (2014). Antiviral Res. 99(1):6-11 (2013). Nat Cell Biol.14(3):295-303 (2012). BMC Biol.8; 11:78 (2013). Biopolymers. 101(4):391-7 (2014).

Customer Reviews

  • New Products

  • 32 New Products Within 30 Days

  • See More >
  • ESI-09
  • "
  • PathWay: Others

    Target: Others

    ESI-09 is a novel noncyclic nucleotide EPAC antagonist that is capable of specifically blocking intracellular EPAC-mediated Rap1 activation and Akt phosphorylation, as well as EPAC-mediated insulin secretion in pancreatic β cells with IC50 of 1.4 uM/3.2 uM for EPAC2/EPAC1 respectively.

  • MORE
  • Brivaracetam
  • "
  • PathWay: Others

    Target: Others

    Brivaracetam(UCB-34714) is a 4-substituted pyrrolidone butanamide as agent with significant antiepileptic activity; high affinity SV2A ligand and also shows an ability to inhibit Na+ channels.

  • MORE
  • AC-55541
  • "
  • PathWay: GPCR/G protein

    Target: Protease-Activated Receptors(PARs)

    AC-55541 is a novel small-molecule protease-activated receptor 2(PAR2) agonist; activated PAR2 signaling in cellular proliferation assays, phosphatidylinositol hydrolysis assays, and Ca(2+) mobilization assays, with potencies ranging from 200 to 1000 nM.

  • MORE